Compare Consolidated Edison, Inc. (ED) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs Tango Therapeutics Inc. — how do they compare? Consolidated Edison, Inc. trades at $110.75 (market cap $40.53B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: Consolidated Edison, Inc. is far larger — about 10.8× Tango Therapeutics Inc.'s market cap, and Consolidated Edison, Inc. pays a 3.2% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Consolidated Edison, Inc. for 76 Days and Tango Therapeutics Inc. for 0 Days on average.
| ED | TNGX | |
|---|---|---|
Market Cap | $40.53B | $3.74B |
Volume | 2,448,266 | 3,438,781 |
Sector | Utilities | Health |
52-Week High | $115.46 | $32.90 |
52-Week Low | $95.37 | $7.50 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $67.38B | $2.76B |
Dividend Yield | 3.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Consolidated Edison (ED) trades at $107.82, up 0.58% on the day, with a bullish technical signal and strong cash flow from operations of $4.80B in 2025. Recent earnings show mixed results, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. The company maintains solid profitability with a net income margin of 12.53% and recently announced a dividend of $0.89 payable in September 2026, highlighting its status as a Dividend Aristocrat.
ED offers stable utility exposure with consistent dividends, but analyst consensus is cautious with 62.96% hold ratings. Risks include high debt levels and regulatory pressures. The stock's current price near the consensus target of $105.56 suggests limited upside, making it suitable for income-focused investors seeking defensive holdings amid market volatility.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
